Susquehanna International Group
IDIX

Susquehanna International Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Susquehanna International Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-304,096
Closed -$7.33M – 10545
2014
Q2 		$7.33M Buy
304,096
+109,934
+57% +$1.15M ﹤0.01% 2506
2014
Q1 		$1.17M Sell
194,162
-62,129
-24% -$433K ﹤0.01% 5229
2013
Q4 		$1.53M Buy
256,291
+172,548
+206% +$798K ﹤0.01% 4731
2013
Q3 		$436K Buy
83,743
+69,971
+508% +$307K ﹤0.01% 6637
2013
Q2 		$50K Buy
+13,772
New +$56.3K ﹤0.01% 7977

Susquehanna International Group's IDIX Position: Q3 2014 in Review

Susquehanna International Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 304,096 shares — an estimated $7.33M sold.

Susquehanna International Group first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $7.33M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Susquehanna International Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Susquehanna International Group sold 304,096 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $7.33M.
  • Susquehanna International Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Susquehanna International Group's IDENIX PHARMACEUTICALS INC position peaked at $7.33M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Susquehanna International Group's 13F filing for Q3 2014, filed 17 Nov 2014.